Pharma should team up with HCPs, regulators and health ministries to create harmonised, interoperable health records and so drive cheaper, faster insights
Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton
Pharma is rapidly adapting its approach to trials in the face of the pandemic and there is great opportunity for far reaching improvements once this is all over
Digital capabilities are proving their worth in the face of the sudden upheavals driven by the pandemic and ongoing investment will pay dividends, says Bertrand Bodson, Novartis CDO
Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague